Skip to main content

Intellia Therapeutics widens losses

Intellia Therapeutics Inc. (Nasdaq: NTLA) widened losses for the fourth quarter sending the stock price plunging $4.41 to close at $28.81.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.